Between a Rock and a Hard Place: How to Use Antithrombotics in Patients Undergoing Transcatheter Aortic Valve Replacement
Transcatheter aortic valve replacement (TAVR) has become the preferred method for management of severe aortic stenosis in patients who are at high and intermediate surgical risk, and has recently gained approval from the Food and Drug Administration in the US for use in patients at low risk for surg...
Guardado en:
Autores principales: | Kelsey Grossman, Mathew R Williams, Homam Ibrahim |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Radcliffe Medical Media
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/67e2a52f23ac48cfa3ef1edd48789692 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Antithrombotic Therapy After Transcatheter Aortic Valve Implantation
por: Leslie Marisol Lugo, et al.
Publicado: (2020) -
Transcatheter aortic valve replacement in patients with bicuspid aortic valve stenosis: national trends and in-hospital outcomes
por: Mohamad Soud, et al.
Publicado: (2020) -
Conduction Abnormalities After Transcatheter Aortic Valve Replacement
por: Somsupha Kanjanauthai, et al.
Publicado: (2019) -
Shockwave and Non-transfemoral Transcatheter Aortic Valve Replacement
por: Eden C Payabyab, et al.
Publicado: (2021) -
Transcatheter aortic valve replacement in patients with previous mitral valve replacement. A systematic study
por: Zbigniew Chmielak, et al.
Publicado: (2020)